An Effective Neutralizing Antibody Against Influenza Virus H1N1 from Human B Cells

An Effective Neutralizing Antibody Against Influenza Virus H1N1 from Human B Cells
复制标题

DOI:
10.1038/s41598-019-40937-4
复制
发表时间:
2019-03-14
期刊:
影响因子:
4.6
通讯作者:
Wang, Andrew H-J
Wang, Andrew H-J
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Lee, Cheng-Chung;Yang, Chih-Ya;Wang, Andrew H-J

文献摘要

被引文献

相似文献

流行性感冒是由流感病毒感染引起的急性呼吸道传染病。血凝素(HA)是流感病毒治疗和诊断检测的重要靶点。甲型流感病毒包括几种不同的HA亚型,具有不同的毒株,这些毒株不断变化。在这项研究中,我们通过EB病毒永生化B细胞为基础的技术,确定了一个完全人H1N1中和抗体(32 D 6)。32 D 6特异性中和2009年大流行后临床分离的H1N1毒株,但不中和早期毒株。通过对32 D 6-Fab/HA 1复合物结构的X射线晶体学分析鉴定了表位,其揭示了位于HA顶表面的独特环构象。主要区域由两个肽段(残基172-177和206-213)组成,其形成并列环构象。两个环之间的残基T262形成用于被32 D 6识别的构象表位。在HA和重链的界面处观察到三个水分子,它们可能构成32 D 6-HA缔合的稳定元素。此外,每个32 D 6-Fab可能能够阻断一个HA三聚体。本研究提供了关于32 D 6的菌株特异性的重要信息,用于病毒感染的治疗性治疗和检测。
Influenza is a contagious acute respiratory disease caused by the influenza virus infection. Hemagglutinin (HA) is an important target in the therapeutic treatment and diagnostic detection of the influenza virus. Influenza A virus encompasses several different HA subtypes with different strains, which are constantly changing. In this study, we identified a fully human H1N1 neutralizing antibody (32D6) via an Epstein-Barr virus-immortalized B cell-based technology. 32D6 specifically neutralizes the clinically isolated H1N1 strains after the 2009 pandemic but not the earlier strains. The epitope was identified through X-ray crystallographic analysis of the 32D6-Fab/HA1 complex structure, which revealed a unique loop conformation located on the top surface of HA. The major region is composed of two peptide segments (residues 172-177 and 206-213), which form an abreast loop conformation. The residue T262 between the two loops forms a conformational epitope for recognition by 32D6. Three water molecules were observed at the interface of HA and the heavy chain, and they may constitute a stabilizing element for the 32D6-HA association. In addition, each 32D6-Fab is likely capable of blocking one HA trimer. This study provides important information on the strain specificity of 32D6 for the therapeutic treatment and detection of viral infection.